TTA’s Thanksgiving Windup: Steward heads investigated, CVS head departs, Congress’ controls over Oracle VA EHR depart, NeuroNinja needs funding, Teladoc, Cortica, 23andMe, Neuralink, more!

November 27, 2024 | by | No Comments

 

 

It’s a short holiday week in the US and the stories range from Potential Big International Fraud to Neuralink’s Big Brain Implant Potential. Yet another CVS head departs. Congressional VA EHR controls also depart in new bill. And help fund the adventures of NeuroNinja, a comic superhero who just happens to be living with Parkinson’s. 

Happy Thanksgiving! New articles resume Monday 2 December.

Short takes: Teladoc intros hospital bed fall risk detector, Veradigm’s AI scribe, Lucid’s pill-sized esophageal cancer diagnostic, Cortica’s $80M raise for autism treatment, LG NOVA startup winners
News roundup: Oak Street’s Pykosz departs CVS, Musk’s Neuralink gains Canadian clinical trial, VA healthcare improvement bill omits EHR oversight measures, 23andMe’s Mirador precision medicine partnership (Another CVS head departs, stage left)
Help fund the NeuroNinja comic–a superhero with Parkinson’s! (An unusual approach)
Breaking: Federal agents seize Steward Health’s CEO, international head’s mobile phones in widening US investigations (It’s big, it’s developing, it’s international)

An unusual pre-Thanksgiving week focused on significant developments on ongoing Major Stories but little new. CVS Health bends the knee to investor Glenview. Controlled substances telehealth gets a 3rd extension. Revere Medical out of Steward ashes snaps up a broken MSO. Oura partners with Dexcom CGM and gets paid for it! What’s kind of new? HHS comes up short on cybersecurity leadership while accurate EHR notes are short in new VA study.

Government updates: GAO scores HHS on cybersecurity issues; patient issues largely omitted from EHR notes in VA study (Coming up consistently short)
News roundup: CVS Health cedes 4 new board seats to Glenview, Oscar’s strong Q3, telehealth controlled substance prescribing in 3rd extension, new Revere Medical to buy CareMax assets, Oura picks up $75M Dexcom financing and partnership (Further developments on Big Stories)

Cue the music…it’s the good, bad, and a ration of ugly this week. An under-the-radar company makes big buys in primary care and MSO. Veradigm might finally get itself sold. DOJ drags UHG to court over Amedisys–after the election. 23andMe continues to perhaps Destination Oblivion. Forward meets Oblivion after eight years. And Ali Parsa, one year after Babylon’s failure, serves up a new AI venture that gets a Gimlety view.

Bad News Roundup updates: UHG/Optum defends Amedisys buy fast via a website, digging deeper into Forward’s fast demise, former Masimo CEO Kiani booted–and sued (One lesson after another)
Bad News roundup: DOJ drops the hammer on UHG-Amedisys, 23andMe lays off 40% and closes therapeutics, Lyra Health lays off 2% in restructuring, Forward primary care + kiosks shuts down abruptly (We aren’t past it yet)
Babylon Health’s Parsa founds new AI medical assistant venture, Quadrivia, one year after Babylon Health’s failure (Parsa’s new AI-powered deal)
M&A action news: Astrana Health buys up Prospect Health for $745M after Centene MSO unit buy, Veradigm nears $1B+ sale, Sword Health lays off 17% of clinicians prepping for IPO using AI instead, Cigna is not buying Humana–really! truly! (M&A comes alive, with a new player)

The Big Race is over, 45 is now 47 come January, and health tech (plus related) news faces future. HLTH’s future is with UK’s Hyve Group. Cerebral faces an expensive DOJ/DEA Judgment Day for its Bad Behavior during the pandemic. 23andMe, CVS, and Walgreens face future survival. And what if in future healthcare sets a goal of zero failures, like aircraft makers and airlines?

News roundup: Cerebral forfeits $3.7M on federal Rx charges, Aetna president named, Stewardship Health sold to Rural Healthcare, Oura buys data company Sparta Science, Brook Health-Linus Health remote cognitive assessment 
Weekend reading: 23andMe’s up in the air future, including genetic data; Walgreens debates What To Stop and Start; what if healthcare pursued a zero-failure rate? (Some reckonings and a future view)
Surprise! HLTH conference group sold to UK’s Hyve Group Limited (Las Vegas barely a wrap)

A post-HLTH deluge of news–as the US rolls up to a major national election. CVS replaces its CEO and debates breaking up. Amwell takes on a new CFO. Decent-sized raises seem to have returned. Cigna isn’t buying Humana–as of now. And has Teladoc turned a corner?

News roundup: Teladoc’s improved Q3, PursueCare resuscitates Pear’s apps, AMA removes 16-day RPM requirement in 2026, PatientPoint intros Innovation Network, PeopleOne’s $32B raise, Cigna-Humana again a no-go (Earnings season and post-HLTH announcements)
Some thoughts on the takeaways from HLTH (Not that many, strangely)
News roundup 23 Oct: views on a CVS breakup and CEO replacement, Amwell’s interesting new CFO, CopilotIQ/Biofourmis merge (updated), raises by HealthEx, Counsel Health, Oshi Health (Will changes at top fix problems?)

As the weather chills, so do prospects for some very well known companies–and investment. Walgreens plans to shrink its retail footprint by 1,200 over the next three years, “monetize” VillageMD. CVS is exiting most of its infusion business. UHG stock, earnings hammered on Change Healthcare hack, Federal payment cuts. Masimo v. Apple patent slugfest continues with wins for both. DEA kicks the can on telehealth waivers into next year–maybe. FTC and DOJ chill M&A with more demanding Premarket Notification rule for M&A. The spot of good news–baby monitoring Owlet has its mojo back.

News roundup 16 Oct: Walgreens shuts 1,200 stores–500 in ’25, CVS exiting core infusion biz, Masimo v. Apple update, DEA recommends 3rd telehealth extension, Change hack costing UHG $705M, Owlet back in NYSE compliance (So many denouements..and only one good)
FTC drops the hammer on premerger notification requirements–what will be M&A and investment effects? (We told..and tell you so, no frills)

It’s unconfirmed, but CVS may be considering a breakup. Teladoc’s latest reorg puts its COO out to pasture. IPOs may revive by next year for ‘overdue for exit’ companies. In CEO Land, one former CEO strikes back at the Senate holding him in contempt, while another one, having lost her board, now can easily take 23andMe private. ATA announces 2025 Nexus and call for papers. And some new fundings and products…and why can’t VA stop stubbing its toe on Oracle EHR issues, or staff diving into politicians’ health records?

News roundup: Omada Health files S-1 for IPO in 2025–and a look at 2024 healthcare IPOs, Philips debuts new smart baby monitor, ActiveAlert launches in UK, ATA Nexus 2025 calls for speakers, abstracts (An small IPO revival?)
Breaking: another exit at Teladoc, with COO resigning effective 31 December (Something about ships? Spirals? Musical chairs?)
Industry news short takes: fundings for Qure.AI, Centivo, Rippl, Surescripts; M&A closings for GE Healthcare-Intelligent Ultrasound, LetsGetChecked-Truepill. And is Hinge Health going public soon?
Two ‘oops’ at VA: OIG finds VA, Oracle performance misalignments, makes 9 recommendations; VP candidates’ EHR records improperly accessed by VA employees (Enough already!)
Two follow ups: Steward Health CEO resigns–and sues the Senate HELP committee, Wojcicki will take 23andMe private (Time to take the yachts for a long trip?)
Now CVS Health may be reviewing ‘options’–including a possible breakup–report (PBM and health plan troubles)

Steward’s CEO will likely face prosecution on criminal contempt of Congress for not showing up at a hearing, Stefano Pessina’s net worth down by 97% as Walgreens tanks, and Joe Kiani, after founding Masimo 35 years ago, is booted from the board and ankles–now it’s up to Politan.  

What’s next for: Steward CEO now in criminal contempt of Congress; Walgreens’ Pessina’s fortune vanishes by 97%; Masimo’s Kiani now a man without a company

It’s the last week of summer and this Editor has been catching up all over. While away, there have been buys, M&A, and yet another PE ‘smush’ merger. In developing stories, the Masimo-Politan proxy war ends and Steward’s CEO no-show may result in charges–both on Thursday. Congress and the industry argue over continuing telehealth prescribing waivers. And it’s hard to see a future for a broke 23andMe controlled by its founder/CEO–and with a board that just exited today. 

News roundup: Owlet expands to EU, mPulse buys Zipari, New Mountain PE merges 3 payment integrity firms in $3B smush, Candid Health’s $29M raise, Oura buys Veri, Bloomer Tech’s cardio bra (M&A activity revives, as does Owlet. Oura doing just fine)
23andMe settles 6.9M data breach lawsuit for $30M. Breaking–all seven independent directors quit ($30M the best they could get–and the board throws the towel at Wojcicki)
Rounding up follow ups: Walgreens shareholder suit on pharmacy performance, Steward CEO no-shows Senate committee, Masimo-Politan proxy fight has court win for Politan–vote on for 19 September (Walgreens’ misery never ends. Masimo nears its end.)
US telehealth controlled substances prescribing waiver may expire at year’s end; DEA may further restrict (Controversy on continuing virtual prescribing of Schedule II)

One more jumbo deal announced before Labor Day–Evolent Health’s acquisition bids from payer Elevance Health as well as at least three large private equity firms, in a deal that could top $4 billion. (Sensibly, their CEO is cleaning up his stock option portfolio.)

Evolent Health talking major acquisition by payer Elevance, private equity (Could be over $4B)

Counting down before the Labor Day holiday, one large deal of note sneaks through–LetsGetChecked’s $525M deal for Truepill. SVB’s latest report confirms the ‘valuation trap’ for the overvalued companies of the 2020-22 period but that investment is crawling back. Generative AI is much talked about but no one is comfortable with it. And two surprising survivals–NeueHealth and Stewardship Health.

Truepill to be acquired by LetsGetChecked for $525 million (Throwing in together to survive?)
Signs of life: another view on healthcare investments and exits as of mid-year (SVB’s 14th POV)
Are patients and physicians ready for generative AI? How will it be most acceptable? (Resembles telehealth’s early days on the early curve)
“I will survive” updates: NeueHealth survives Q2 with small net loss, Steward sells off Stewardship Health practices to private equity firm for $245M (Dodging disaster)

Have a job to fill? Seeking a position? See jobs listed with our new job search partner Jooble in the right sidebar!

Read Telehealth and Telecare Aware: https://telecareaware.com/  @telecareaware

Follow our pages on LinkedIn and on Facebook

We thank our advertisers and supporters: Legrand, UK Telehealthcare, ATA, The King’s Fund, DHACA, HIMSS, MedStartr, and Parks Associates.

Reach international leaders in health tech by advertising your company or event/conference in TTA–contact Donna for more information on how we help and who we reach. 

Telehealth & Telecare Aware: covering the news on latest developments in telecare, telehealth, telemedicine, and health tech, worldwide–thoughtfully and from the view of fellow professionals

Thanks for asking for update emails. Please tell your colleagues about this news service and, if you have relevant information to share with the rest of the world, please let me know.

Donna Cusano, Editor In Chief
donna.cusano@telecareaware.com

– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –

Help fund the NeuroNinja comic–a superhero with Parkinson’s! (Update–it funded!)

November 26, 2024 | by | No Comments

Turning Parkinson’s into an adventure story. Steven Greene, an old friend of your Editor Donna and owner of a marketing agency, was diagnosed in 2009 with Parkinson’s. He has had all sorts of treatments and therapies during 15 years with it, including brain stimulation surgery. Steve’s experiences led him to develop a comic series, NeuroNinja, targeted to the Parkinson’s community. Our hero Steven, during surgery, experiences a freak accident involving an MRI machine and a quantum computer (left/above). Their convergence causes his brain to fuse with a cutting-edge technology, transforming him into NeuroNinja! He remains unsteady, unpredictable, and has Parkinson’s tremors. But NeuroNinja is, in Steve’s words, “a hero who reflects their daily reality, someone who embodies resilience, strength, and hope in the face of adversity. NeuroNinja is more than just a comic; it’s a symbol of perseverance, a reminder that even with a chronic illness, we can be heroes in our own lives. He uses his symptoms and unique abilities to fight evil, navigate challenges, and help others. His ultimate power? The strength to fight through his own struggles, because sometimes the greatest battles are the ones we face within ourselves.”

The series, completed through key panels and the first issue, is being funded through a Kickstarter that so far has raised just above $6,100, exceeding its $6,000 goal. It has three days left to go, so please look at Steve’s video and the entire proposal–and donate!

Update–NeuroNinja is funded! The Kickstarter exceeded its $6,000 goal at $6,350 backed by 54 people. Kickstarter has a feature called ‘late pledge’–click on the ‘back this project’ button. There are rewards available at the $65 and $200 levels and pledges of other amounts are welcomed too for the next 50-odd days.

Apps and wearables – developments over the summer

August 26, 2015 | by

Trying at least temporarily to distract this editor’s attention from his recent unfortunate experience with Jawbone technology, here are some interesting app and wearables snippets received over the summer.

We begin with news of the first CE certified mole checking app, SkinVision which rates moles using a simple traffic light system (using a red, orange or green risk rating). The app lets users store photos in multiple folders so they can track different moles over time. It aims to detect changing moles (color, size, symmetry etc.) that are a clear sign that something is wrong and that the person should visit a doctor immediately.

This contrasts with the findings of a paper published in June examining 46 insulin calculator apps, 45 of which were found to contain material problems, resulting in the conclusion that :”The majority of insulin dose calculator apps provide no protection against, and may actively contribute to, incorrect or inappropriate dose recommendations that put current users at risk of both catastrophic overdose and more subtle harms resulting from suboptimal glucose control.”, which to say the least of matters is worrying. (more…)

3rings smart plug fundraising on Kickstarter

June 19, 2015 | by
[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2015/06/3rings.gif” thumb_width=”150″ /]A note from founder and chairman Steve Purdham brings the news that the 3rings smart plug [TTA 11 Mar], which tracks an older one’s activity through everyday actions such as turning on an electric tea kettle or TV and radio on, is raising funds on Kickstarter through 13 July. Their goal is $30,709 (£20,000) of which $10,306 (£6,712) has been raised with 24 days to go. With product design and testing complete, the funds will go towards facilitating production. Pledges start at £2 and go up to £5,000 for practically everything listed in the lower donation levels, a special evening in Oxford for two and an autographed, personalized picture and autobiography of Manchester United and Scotland legend Willie Morgan. Note: the 3rings plug and service is only available in the UK, but if the service is available later in your country, any subscription pledges will be honored. Best of luck to Steve and the 3rings team! Release.

An alert watch for older adults that responds to voice commands

February 18, 2015 | by | 3 Comments
[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2015/02/UnaliWear_Images_r6_c4.jpg” thumb_width=”150″ /]This Editor has been in Watch Overload (see Apple Watch) for months, but this may be an exception. The UnaliWear Kanega watch (in development) is for the sizable market of older adults who would wear a well-designed watch or band for safety assistance, but not one that screams Old Person With Plastic PERS, an objective shared with the latest edition of buddi [TTA 16 Dec 14]. Their prototype looks like a fairly techno steel watch, a little on the chunky side, but it packs in a lot: a 9-axis accelerometer for fall detection, a GPS locator, Bluetooth LE, cellular/Wi-Fi connectivity and a digital analog display with time and date. What’s unique: no buttons, smartphone or other tether. It works via speech recognition and ‘talks with’ the wearer (via mechanical voice, messaging on the display and a feed to a BLE hearing aid if worn.) (more…)

Eimo UK telehealth device fundraising via Kickstarter

July 24, 2014 | by
[grow_thumb image=”https://telecareaware.com/wp-content/uploads/2014/07/Eimo.jpg” thumb_width=”190″ /]Updated 25 July    If our exclusive on the ‘tricorder-like’ Eimo device caught your attention [TTA 19 May], you will be interested in the extra information about it given on its Kickstarter page. See the second video down and read some more on its background, history and the philosophy of the developers, iMonSys, located in North Yorkshire. You may even want to pledge some cash to help produce the first 1,000 units! (Unfortunately, funding stands at only £2,000 of a required £145,000 pledge by Wednesday, 13 August.) iMonSys will also be developing two versions: for home use to retail at £300 and the medical version to retail at £600. What is different about this is that based on the demo, anyone can be taught to use Eimo and it produces a reading of core body temperature, full ECG trace, oxygen levels, pulse and blood pressure in well under two minutes as seen in the video. Also it stores data so that the ‘funny turn’ that doesn’t consistently happen can also be captured and stored for later analysis by a doctor. Will it actually be a vital signs monitor ‘which even Granny can use’? Based on the video it certainly seems so.

Update: Laurie Orlov picks up iMonSys’ local roots in Staithes in her post on Boomer Health Tech Watch linking to an article in the Whitby Gazette. Founder and developer Graham Priestley’s original concept resembled the ‘black box’ on an aircraft to monitor a soldier’s vital signs, with the original research under the aegis of the (UK) Ministry of Defence but shelved around 2008. He picked this up two years later with the assistance of the University of Hull, and is currently seeking to

Our readers can help spread the word on this UK product on Kickstarter!